Literature DB >> 28012866

Epidemiological updates of venous thromboembolism in a Chinese population.

Yuk Law1, Yiu Che Chan2, Stephen W K Cheng2.   

Abstract

BACKGROUND/
OBJECTIVE: Deep vein thrombosis (DVT) was thought to be uncommon in Asians and routine thromboprophylaxis in the form of anticoagulation for surgical patients was considered to be unnecessary. The current study aims to provide a contemporary epidemiology of venous thromboembolism in a population-based scale.
METHODS: Information from January 1, 2010 to December 31, 2011 was retrieved from a centralized computer public healthcare database serving mainly an ethnic Han Chinese population of 7.1 million. The incidence, demographics, and hospital mortality rates of DVT and pulmonary embolism (PE) were obtained, and analyzed for different surgical categories.
RESULTS: The overall annual incidences of DVT, PE alone, and PE with DVT were 30.0 per 100,000 population, 8.7 per 100,000 population, and 3.0 per 100,000 population, respectively. Overall male to female ratio was 1:1.24. Venous thromboembolic disease was more common with increasing age in both sexes. Thirty days' mortality rates associated with DVT, PE alone, and PE with DVT were 9.0%, 17.4%, and 13.3% respectively. Among the patients who received 103,023 major and intermediate surgical procedures in the study period, the mean incidence of postoperative DVT, PE alone, and PE with DVT were only 0.20% (203.5 patients), 0.08% (85.5 patients), and 0.04% (40.5 patients) respectively.
CONCLUSION: Compared with a similar study 10 years ago, there seemed to be a general increase in incidence of DVT and PE. This study showed that postoperative thromboembolic events were not uncommon, with DVT occurring in up to 0.2% of patients and PE in 0.12% of patients in this longitudinal survey.
Copyright © 2016. Published by Elsevier Taiwan.

Entities:  

Keywords:  Han Chinese; deep vein thrombosis; epidemiology; mortality; pulmonary embolism

Mesh:

Year:  2016        PMID: 28012866     DOI: 10.1016/j.asjsur.2016.11.005

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  10 in total

1.  Incidence of Venous Thromboembolism: The 3rd Korean Nationwide Study.

Authors:  Hun-Gyu Hwang; Ju Hyun Lee; Sang-A Kim; Yang-Ki Kim; Ho-Young Yhim; Junshik Hong; Soo-Mee Bang
Journal:  J Korean Med Sci       Date:  2022-05-02       Impact factor: 5.354

2.  Bidirectional risk between venous thromboembolism and cancer in East Asian patients: synthesis of evidence from recent population-based epidemiological studies.

Authors:  Victor C Kok
Journal:  Cancer Manag Res       Date:  2017-12-05       Impact factor: 3.989

3.  Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis.

Authors:  Fruzsina Demeter; Tamás Gyöngyösi; Zsuzsanna Bereczky; Katalin E Kövér; Mihály Herczeg; Anikó Borbás
Journal:  Sci Rep       Date:  2018-09-13       Impact factor: 4.379

4.  [Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Epidemiological Characteristics].

Authors:  Yixin Sun; Hui Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-12-20

5.  Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia.

Authors:  Lei Li; Lixia Gao; Xi Wu; Wenman Wu; Qiulan Ding; Xuefeng Wang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

6.  Correlation between serum factor VIII:C levels and deep vein thrombosis following gynecological surgery.

Authors:  Jiayi Liu; Cuiqin Sang; Zhenyu Zhang; Ying Jiang; Shuzhen Wang; Yao Li; Xiao Shi
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study.

Authors:  Li Li; Jia Zhou; Liquan Huang; Junhai Zhen; Lina Yao; Lingen Xu; Weimin Zhang; Gensheng Zhang; Qijiang Chen; Bihuan Cheng; Shijin Gong; Guolong Cai; Ronglin Jiang; Jing Yan
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

8.  Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China.

Authors:  Li Yang; Jingjing Wu
Journal:  BMJ Open       Date:  2020-07-30       Impact factor: 2.692

9.  Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery.

Authors:  Ruidi Yu; Faridah Nansubuga; Jun Yang; Wencheng Ding; Kezhen Li; Danhui Weng; Peng Wu; Gang Chen; Ding Ma; Juncheng Wei
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

10.  The Risk Factors of VTE and Survival Prognosis of Patients With Malignant Cancer: Implication for Nursing and Treatment.

Authors:  Yan Qi; Xin Hu; Jing Chen; Xiaobin Ying; Yan Shi
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.